|
|
|
Volumn 26, Issue 2, 1999, Pages 185-191
|
|
Chemotherapy of advanced prostatic carcinoma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EPIRUBICIN;
ESTRAMUSTINE;
ETOPOSIDE;
FLUOROURACIL;
GEMCITABINE;
KETOCONAZOLE;
MITOMYCIN C;
NAVELBINE;
PACLITAXEL;
ADVANCED CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
DRUG EFFICACY;
HUMAN;
MALE;
PRIORITY JOURNAL;
PROSTATE CARCINOMA;
REVIEW;
ANTINEOPLASTIC AGENTS, HORMONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA;
COMBINED MODALITY THERAPY;
DISEASE PROGRESSION;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
MALE;
PALLIATIVE CARE;
PROSTATIC NEOPLASMS;
RADIOTHERAPY, ADJUVANT;
REMISSION INDUCTION;
SURVIVAL RATE;
|
|
EID: 0032939525
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (31)
|
|
References (49)
|
